Author: Ananda Public Affairs

GREENWOOD VILLAGE, Colo. & NEW YORK (BUSINESS WIRE) – ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a second clinical trial to evaluate the effect of cannabidiol in ANANDA’s proprietary delivery technology on opioid sparing in participants with chronic radiculopathic pain syndromes maintained on opioid therapy. An Investigational… Continue reading Cannabidiol (CBD) and Chronic Radiculopathic Pain Syndromes


GREENWOOD, Colo. & NEW YORK, January 12, 2021 – ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a new clinical trial evaluating the efficacy of cannabidiol in ANANDA’s proprietary delivery technology as a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms and Neurocognitive Impairment in patients with PTSD and… Continue reading Cannabidiol (CBD) for Treatment of
 Post-Traumatic Stress Disorder (PTSD)

GREENWOOD, Colo., September 8, 2020 – ANANDA Scientific Inc., a biotech pharma company, today announced that Sohail Zaidi has been appointed as ANANDA’s new President. “Sohail Zaidi is already proving to be an extraordinary leader who has been flawlessly executing our pioneering clinical trial program, and we are thrilled to continue pursuing ANANDA’s strategic vision… Continue reading ANANDA Scientific Appoints Sohail Zaidi as its New President

GREENWOOD, Colo., August 18, 2020 – ANANDA Scientific Inc., a biotech pharma company, today announced that John Suh, previously CEO of LegalZoom, has been appointed to ANANDA’s Board of Directors as its new Executive Director. “We are very pleased to welcome John as Executive Director of the ANANDA Board of Directors,” said Mark J. Rosenfeld,… Continue reading John Suh Joins ANANDA Scientific’s Board of Directors as 
Executive Director

GREENWOOD, Colo., April 1, 2020 (Newswire.com) – ANANDA Scientific, a biotech pharma company, today announced that its clinical research team will initiate trials to assess the company´s proprietary Liquid Structure™ Cannabidiol (CBD) formulation as a treatment for mitigating the impact of COVID-19 infections, specifically, the “cytokine storms” that result from an excessive production of immune system… Continue reading ANANDA Scientific Initiates Clinical Trial for COVID-19

  GREENWOOD, Colo., March 17, 2020 (Newswire.com)   ANANDA Scientific, a clinical-stage biotech company pioneering patented delivery technologies for cannabinoids and other plant-derived compounds, today announced the launch of a new science-based breakthrough for effective delivery of CBD in beverages. This new water-stable formulation of ANANDA’s patented, high-bioavailability Liquid StructureTM CBD corrects many of the… Continue reading ANANDA Scientific Debuts Beverage-Stable CBD Formulation

GREENWOOD, Colo. (Newswire.com)   ANANDA Scientific, a clinical-stage biotech company that is trailblazing patented delivery technologies for cannabinoids and other plant-derived compounds, announced today that it has initiated its first human clinical trial for its Nano-Sized Self-assembled Liquid Structure™ CBD Formulation. This human clinical trial is designed to assess the bioavailability and safety of ANANDA’s… Continue reading ANANDA Scientific Initiates Human Clinical Trial for Liquid Structure™ CBD Formulation

  GREENWOOD, Colorado — November 8, 2019 —   ANANDA Scientific today announced the appointment of Maypro Industries, one of the largest global suppliers of nutraceutical ingredients, as the company’s Sales and Distribution Partner in the United States on the heels of SupplySide West in Las Vegas.   “We are thrilled to bring on Maypro… Continue reading ANANDA Scientific Appoints Maypro as U.S. Sales and Distribution Partner